Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update evaluating HS-10374 for moderate to severe plaque psoriasis to assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2 trial of cedirogant (ABBV-157) in adults with moderate to severe psoriasis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LZM012 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of LZM012 for psoriasis is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Vtama in Psoriasis Patients Being Treated With Biologics. [Phase 4]
Phase 4 clinical trial update for Vtama in patients with psoriasis who are being treated with biologics.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 clinical trial of guselkumab in Chinese participants with moderate to severe plaque psoriasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial of NDI-034858 in moderate to severe plaque psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 [Phase 1]
A Phase 1 trial evaluating tolerability of varying doses of BI 730357 in healthy men and how BI 730357 affects the metabolism of midazolam, …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of the infliximab biosimilar Remsima in psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis [Phase 1]
Phase 1 clinical trial update for LY3316531 in healthy participants and psoriasis patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Efficacy and Safety of Apremilast in Psoriasis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of apremilast in psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating safety and efficacy of expanded allogeneic adipose-derived mesenchymal stromal cells in pati…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing PSORI-CM01 formula to Gu Ben Hua Yu formula combined with AD-MSCs in psoriasis is underway, with an unk…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the efficacy and safety of adipose-derived mesenchymal stromal cells (AD-MSCs) plus calipcitriol ointmen…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis [Phase 1]
Phase 1 trial of a single dose of spesolimab in generalized pustular psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating the safe and effective use of the prefilled syringe or auto-injector for subcutaneous self-injection of bimekizumab…
-
FDA label_change · 2023-07-17FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for Betamethasone Dipropionate from Viona Pharmaceuticals Inc, typically reflecting labeling cha…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Chinese Medicine for Patients With Psoriasis [Phase 2]
A Phase 2 clinical trial update investigating Chinese Medicine for patients with psoriasis is listed, with the sponsor as The Chinese Univer…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Efficacy of Roflumilast in the Treatment of Psoriasis [Phase 2]
Phase 2 clinical trial update on roflumilast for psoriasis has completed evaluating efficacy.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Roflumilast Versus Methotrexate in Psoriasis [Phase 2, Phase 3]
Clinical trial comparing roflumilast to methotrexate in psoriasis has completed Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis [Phase 4]
Phase 4 clinical trial examining the effects of biological agents on vascular and cardiac function in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis [Phase 3]
Phase 3 study evaluating guselkumab in adults with moderate-to-severe plaque psoriasis has completed and posted results (May 10, 2023).
-
FDA label_change · 2023-05-10FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis [Phase 2]
Phase 2 trial of once-weekly oral aminopterin for moderate-to-severe psoriasis has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2023-03-31Clinical Trial Update: An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound [Phase 4]
Phase 4 trial of secukinumab in plaque psoriasis with subclinical psoriatic arthritis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis [Phase 3]
Phase 3 randomized placebo-controlled study of ISA247 in plaque psoriasis completed with results posted.